Meredith hay, ph.d.

Founder and Chief Executive Officer

Meredith is the visionary and one of the inventors of the founding technology. She has over 30 years of experience in neuroscience and cardiovascular neurophysiology.  She is the former Executive Vice President and Chief Operating Officer for the University of Arizona for former Vice President for Research, University of Iowa.  She currently is a tenured professor at the University of Arizona College of Medicine. Dr. Hay has generated over $50 M in external R&D funding and nearly 30 NIH and related grants.

crockett.jpg

Tamara Crockett, Esq

Director and IP Advisor

Tamara brings a wealth of experience in technology commercialization, intellectual property, technology transfer, start-ups and early stage commercialization to this project.  She has over 25 years of experience in technology development,  intellectual property, contract negotiation and commercialization of emerging technologies.  She most recently served as Senior Counsel for Accenture, plc, a leading multinational technology consulting firm. She  is licensed to practice law in the states of NY, MA, DC and AZ.  

peter knauer.jpg

peter knauer

Director of Regulatory Affairs and Manufacturing

Peter has 30+ years' experience in leading CMC and regulatory activities in the biomedical industry. Peter has held various positions, including Chief Regulatory Officer, Chief Operations Officer, Vice President of CMC and Head of Operations for several US-based companies. Peter started his career at Genentech, where he held several technical and leadership positions in pharmaceutical development and manufacturing and drug delivery.

Chris Rhodes, Ph.D.

Peptide Formulation Development

Chris has more than 35 years' experience in peptide chemistry, manufacturing and therapeutics development including Executive Director of R&D at Amylin Pharmaceutical, and CEO and Founder of Drug Delivery Experts, San Diego, Ca.

Nina Ossanna, ph.d.

Director of Product Development

Nina brings broad experience in both the technical and business side of the pharmaceutical industry.   Dr. Ossanna  manages product development and partner relationships and has extensive experience in  IND development and multicenter clinical trails.